Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 11/2020

01-11-2020 | COVID-19 | Concise Research Report

Health and Social Precarity Among Americans Receiving Unemployment Benefits During the COVID-19 Outbreak

Authors: Adam W. Gaffney, MD, David U. Himmelstein, MD, Danny McCormick, MD, Steffie Woolhandler, MD

Published in: Journal of General Internal Medicine | Issue 11/2020

Login to get access

Excerpt

The Coronavirus Aid, Relief, and Economic Security (CARES) Act provided a $600/week supplement to unemployment benefits which expired July 31. Its extension is controversial. We examined health and social vulnerabilities among those receiving unemployment benefits during the COVID-19 outbreak to inform debate on the consequences of allowing the supplement to lapse. …
Literature
1.
Wozniak A, Willey J, Benz J, Hart N. COVID Impact Survey: Versions 1.3, 2.2, and 3. National Opinion Research Center; 2020.
2.
3.
4.
5.
6.
Metadata
Title
Health and Social Precarity Among Americans Receiving Unemployment Benefits During the COVID-19 Outbreak
Authors
Adam W. Gaffney, MD
David U. Himmelstein, MD
Danny McCormick, MD
Steffie Woolhandler, MD
Publication date
01-11-2020
Publisher
Springer International Publishing
Keyword
COVID-19
Published in
Journal of General Internal Medicine / Issue 11/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06207-0

Other articles of this Issue 11/2020

Journal of General Internal Medicine 11/2020 Go to the issue

Concise Research Report

Single-Item Burnout Measure Correlates Well with Emotional Exhaustion Domain of Burnout but Not Depersonalization Among Medical Students

Original Research

Lifestyle Habits Associated with Weight Regain After Intentional Loss in Primary Care Patients Participating in a Randomized Trial

Healing Arts

Unintended Consequences

Healing Arts

Emerging from the Epicenter: Reflections on the COVID-19 Pandemic

Concise Research Report

Racial Disparities Vary by Patient Life Expectancy in Screening for Breast, Prostate, and Colorectal Cancers

Healing Arts

Medical Students in the Time of COVID-19
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits